Gevo, Inc.
NASDAQ:GEVOChemicals - Specialty
+$0.04 today
- Market cap
- $420.54M
- Beta
- 0.99
- P/E (TTM)
- -10.7
- EPS (TTM)
- -$0.14
Volume 2.74M
Average 3.88M
GEVO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Gevo, Inc.NASDAQ: GEVO
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$9.14M, compared with -$12.86M a year earlier. Trailing-twelve-month EBITDA was $15.99M.
Context
- EBITDA amounted to 6.4% of revenue in FY2025, down 327.4 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 2 analysts of $53.18M (+418.7%) for the fiscal year ending Dec 2026, a step up from the +118.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$9.14M-257.3% QoQ
- Last fiscal yearDec 2025
- $10.25M+118.2% YoY
- LTMMar 2026
- $15.99M+128.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +28.9% | -48.4% | -77.3 pp |
| 1 year | +118.2% | +418.7% | +300.5 pp |
| 3-year CAGR | — | +119.1% | — |
| 5-year CAGR | +90.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 10.25M USD
- Year-over-year change
- +118.2%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.25M | +118.2% |
| FY2024 | 2024-12-31 | (56.46M) | -25.3% |
| FY2023 | 2023-12-31 | (45.05M) | +49.4% |
| FY2022 | 2022-12-31 | (88.95M) | -65.3% |
| FY2021 | 2021-12-31 | (53.82M) | — |
EBITDA vs competitors
How GEVO compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +128.8% is the 2nd highest of 11, against a peer median of -13.5%.
- EBITDA amounts to 9.2% of revenue for GEVO, versus a peer median of 11.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $252.23M USD | -2.0% | +4.9% | 13.4% | |
| LTM Mar 2026 | $192.7M USD | +32.1% | — | 9.7% | |
| LTM Mar 2026 | $164.47M USD | +116.7% | -27.4% | 25.6% | |
| LTM Mar 2026 | $143.17M USD | +374.2% | +5.5% | 7.4% | |
| LTM Mar 2026 | $95.71M USD | -48.1% | -21.8% | 6.2% | |
| LTM Mar 2026 | $66M USD | -84.7% | -57.7% | 2.3% | |
| LTM Mar 2026 | $15.99M USD | +128.8% | — | 9.2% | |
| LTM Mar 2026 | -$2.9M USD | -101.0% | -53.8% | 0.2% | |
ADURAduro Clean Technologies Inc. | LTM Feb 2026 | -CA$17.51M CAD | -81.2% | — | 7238.4% |
| LTM Mar 2026 | -$19.76M USD | +0.9% | — | 8129.7% | |
| LTM Mar 2026 | -CA$56.51M CAD | -25.0% | — | 360.0% | |
| Peer median (excluding GEVO) | — | -13.5% | -24.6% | 11.6% | |
Competitors are the stored peer set for GEVO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 533K | 1.18M | 17.2M | 16.92M | 160.58M |
| Cost of Revenue | 7.69M | 8.7M | 11.99M | 12M | 112.04M |
| Gross Profit | (7.15M) | (7.52M) | 5.21M | 4.91M | 48.54M |
| Gross Margin | -1342.2% | -640.3% | 30.3% | 29.0% | 30.2% |
| Research & Development | 17.36M | 17.49M | 6.64M | 23.74M | 4.55M |
| Selling, General & Admin | 25.49M | 39.94M | 42.63M | 45.8M | 51.2M |
| Operating Expenses | 53.11M | 95.16M | 87.04M | 95.74M | 67.41M |
| Depreciation & Amortization | 5.13M | 7.89M | 19.01M | 18.3M | 25.32M |
| EBITDA | (53.82M) | (88.95M) | (45.05M) | (56.46M) | 10.25M |
| EBITDA Margin | -10098.3% | -7570.5% | -261.9% | -333.8% | 6.4% |
| Operating Income | (60.27M) | (102.69M) | (81.84M) | (90.82M) | (18.87M) |
| Operating Margin | -11307.3% | -8739.2% | -475.8% | -536.9% | -11.7% |
| Interest Income | 571K | 3.48M | 19.09M | 15.74M | 7.81M |
| Interest Expense | 251K | 1.17M | 2.16M | 3.88M | 17.56M |
| Other Income / Expenses | 1.07M | 4.68M | 15.62M | 12.18M | (13.76M) |
| Income Before Tax | (59.2M) | (98.01M) | (66.22M) | (78.64M) | (32.63M) |
| Pre-Tax Margin | -11107.5% | -8341.0% | -385.0% | -464.9% | -20.3% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (59.2M) | (98.01M) | (66.22M) | (78.64M) | (33.84M) |
| Net Margin | -11107.5% | -8341.0% | -385.0% | -464.9% | -21.1% |
| EPS (Basic) | (0.30) | (0.44) | (0.28) | (0.34) | (0.14) |
| EPS (Diluted) | (0.30) | (0.44) | (0.28) | (0.34) | (0.14) |
| Weighted Avg Shares | 195.79M | 221.54M | 238.69M | 231.67M | 234.01M |
| Weighted Avg Shares (Diluted) | 195.79M | 221.54M | 238.69M | 231.67M | 234.01M |
Gevo, Inc.
NASDAQ:GEVO
Intrinsic Alpha fair value
Locked
Current Price
$1.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.